Abbott Laboratories (ABT) Q4 FY24 Earnings Recap | Revenue & EPS Up YoY
In this video, we dive into Abbott Laboratories' Q4 2024 earnings report, breaking down:
• Revenue performance: $10.97B reported, up 7.1% YoY
• EPS growth: $1.34, a 12.6% YoY increase
• Gross margin expansion and operational efficiency gains
• Key business drivers, including innovations in CGM and Structural Heart segments
• Global market expansion strategies
Discover how Abbott is positioning itself for sustainable growth and innovation in 2025 and beyond.
If you enjoy quick, insightful earnings recaps, hit that subscribe button and stay tuned for more from Earnings Central!
#AbbottLabs #EarningsReport #FinanceNews #InvestorInsights #StockMarket